The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $12.24

Today's change-0.71 -5.48%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $12.24

Today's change-0.71 -5.48%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.

Ironwood Pharmaceuticals Inc crosses below 20-day moving average

Ironwood Pharmaceuticals Inc closed sharply lower Friday, dropping (U.S.)$0.71 or 5.48% to (U.S.)$12.24 and crossing below its 20-day moving average. Shares have lost 2.47% over the last five days, but have gained 5.61% over the last year to date. This security has outperformed the S&P 500 by 3.91% during the last year.

Key company metrics

  • Open(U.S.) $12.29
  • Previous close(U.S.) $12.95
  • High(U.S.) $12.55
  • Low(U.S.) $12.04
  • Bid / Ask(U.S.) $7.79 / (U.S.) $0.00
  • YTD % change+5.61%
  • Volume2,278,266
  • Average volume (10-day)1,095,935
  • Average volume (1-month)1,214,804
  • Average volume (3-month)1,602,942
  • 52-week range(U.S.) $7.35 to (U.S.) $13.27
  • Beta1.63
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.86
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue66534028
Total other revenue--------
Total revenue66534028
Gross profit66534020
Total cost of revenue0008
Total operating expense68596670
Selling / general / administrative36323033
Research & development32282629
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--09--
Other operating expenses, total--------
Operating income-2-6-26-42
Interest income (expense), net non-operating-10-10-10-6
Gain (loss) on sale of assets--------
Other--------
Income before tax-13-14-47-48
Income after tax-13-14-47-48
Income tax, total--------
Net income-13-14-47-48
Total adjustments to net income--------
Net income before extra. items-13-14-47-48
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-14-47-48
Inc. avail. to common incl. extra. items-13-14-47-48
Diluted net income-13-14-47-48
Dilution adjustment----0--
Diluted weighted average shares144143142142
Diluted EPS excluding extraordinary itemsvalue per share-0.09-0.10-0.33-0.34
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.09-0.10-0.27-0.34